Correlation Between Nike and Opus Genetics,
Can any of the company-specific risk be diversified away by investing in both Nike and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nike and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nike Inc and Opus Genetics,, you can compare the effects of market volatilities on Nike and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nike with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nike and Opus Genetics,.
Diversification Opportunities for Nike and Opus Genetics,
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Nike and Opus is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Nike Inc and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Nike is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nike Inc are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Nike i.e., Nike and Opus Genetics, go up and down completely randomly.
Pair Corralation between Nike and Opus Genetics,
Considering the 90-day investment horizon Nike Inc is expected to generate 0.47 times more return on investment than Opus Genetics,. However, Nike Inc is 2.11 times less risky than Opus Genetics,. It trades about -0.02 of its potential returns per unit of risk. Opus Genetics, is currently generating about -0.07 per unit of risk. If you would invest 9,531 in Nike Inc on September 3, 2024 and sell it today you would lose (1,654) from holding Nike Inc or give up 17.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nike Inc vs. Opus Genetics,
Performance |
| Timeline |
| Nike Inc |
| Opus Genetics, |
Nike and Opus Genetics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nike and Opus Genetics,
The main advantage of trading using opposite Nike and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nike position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.The idea behind Nike Inc and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Opus Genetics, vs. Vincerx Pharma | Opus Genetics, vs. Viracta Therapeutics | Opus Genetics, vs. Dogwood Therapeutics, | Opus Genetics, vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |